Indo Us Biotech Limited
NSE: INDOUSINE250Z01010·Fast Moving Consumer Goods·www.indousagriseeds.com ↗·Mcap ₹155 Cr·Listed 2024
₹77.60▼ ₹0.46  (−0.59%)
52W: ₹70 – ₹159 · Vol: 2.5K shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q2 FY25
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q2 FY25
Revenue from operations332622.861.630.833.422.2
Other income0.100000.10
Total expenses3023.719.653.32629.617.7
EBITDA43.24.29.65.54.65.1
EBITDA margin12.0%12.4%18.2%15.6%17.8%13.7%23.1%
Finance costs0.70.60.80.90.50.30.5
Depreciation0.30.30.20.40.20.60.2
Profit before tax3.12.43.28.44.83.94.4
Tax00.40.20.20.10.20.1
Net profit3238.24.73.74.4
Net margin9.2%7.6%13.1%13.2%15.3%11.0%19.7%
EPS (₹)1.510.981.494.062.351.862.16
Net profit YoY−35.4%−46.5%–+87.1%–––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25
Revenue from operations110104
Other income0.10.2
Total expenses96.687.5
EBITDA1718.9
EBITDA margin15.4%18.2%
Finance costs2.21.5
Depreciation0.91.1
Profit before tax13.916.5
Tax0.80.3
Net profit13.116.3
Net margin11.9%15.7%
EPS (₹)6.548.12
Net profit YoY−19.3%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25
Operating cash flow−16.1−1.4
Investing cash flow3.3−0.8
Financing cash flow24.4−1.5
Capital expenditure−2.40
Free cash flow (CFO − capex)−18.5−1.4

Net profit trend

annual, ₹ crore
FY25
₹16.3
FY26
₹13.1−19%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone12 Aug 2026 PDF XBRL
Q1 FY27Standalone–PDF on NSE XBRL
Q4 FY26Standalone · audited29 May 2026 PDF XBRL
Q4 FY26Standalone · audited–PDF on NSE XBRL
Q3 FY26Standalone21 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone–PDF on NSE XBRL
Q2 FY26Standalone–PDF on NSE XBRL
Q2 FY26Standalone15 Nov 2025 PDF XBRL
Q1 FY26Standalone– PDF XBRL
Q1 FY26Standalone13 Aug 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 16.7×9.6×
P/B5Y avg 4.35×1.68×
ROEFY26, on average equity15.3%
Net margin11.9%
Debt / equity0.40×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹8.06
Market cap₹156 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
1.68×
vs 4-point avg 4.35× (−61%)
1.68× low4.35× avg8.40× high
History points are balance-sheet dates (2024 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹133 Cr+36%
Net worth₹93 Cr+18%
Total borrowings₹37 Cr+150%
Cash & bank balances₹6 Cr+2371%
Investments₹0 Cr
Inventories₹100 Cr+41%
Trade receivables₹14 Cr−8%
Trade payables₹0 Cr−61%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Sept 24
Promoter68.2968.2970.1770.1770.1770.1770.1770.1770.17
FII0.010.18–––0.000.000.000.00
Retail24.5124.4623.6924.1424.3624.3424.2123.8023.79
Other public7.197.076.145.695.475.495.626.036.04
4,690 shareholders · NSE shareholding pattern filings.